Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement.
Across FY2007–FY2025: $16.14B in buybacks, $4.79B in dividends.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
Related accounting measures — not additional borrowing
Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
Noncurrent debt carrying amount
USD 11,444,086,000
2 filing observations remain unmatched and are excluded from instrument histories.
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
2 filings have incomplete source or extraction coverage. Verified observations are shown; missing observations do not establish that debt was unchanged. 1 legal exhibit was not safely readable, so covenant coverage is incomplete.
Covenants
Some sections could not be verified in 3 agreement documents. Other restrictions or tests may apply.
Verified tests, triggers and restrictions appear with each agreement below. A verified term does not establish current compliance.
Loans, facilities and notes
3.950% Senior Notes due 2029
Note · Cencora, Inc.
Reference: 3.950% Senior Notes due 2029
Active
Original principal
USD 500,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
—
Last reported interest terms:
3.95%
Reported 2026-02-13Later filings may not restate these terms; this does not confirm they still apply.
Verified covenant terms
Section 5.02 · Liens**Section 5.02. *Liens.*** The Company will not, and will not permit any of its Restricted Subsidiaries to, directly or indirectly, create, incur, assume or suffer to exist any Lien of any kind securing Indebtedness on any asset now owned or hereafter acquired, except Permitted Liens, unless (a) in the case of the Company, the 2029 Notes are secured by such Lien equally and ratably with, or prior to, the Indebtedness secured by such Lien or (b) in the case of any Guarantor, such Guarantor’s Guarantee with…Section 5.02. *Liens.*Full wording and supporting evidence
Source evidence: **Section 5.02. *Liens.*** The Company will not, and will not permit any of its Restricted Subsidiaries to, directly or indirectly, create, incur, assume or suffer to exist any Lien of any kind securing Indebtedness on any asset now owned or hereafter acquired, except Permitted Liens, unless (a) in the case of the Company, the 2029 Notes are secured by such Lien equally and ratably with, or prior to, the Indebtedness secured by such Lien or (b) in the case of any Guarantor, such Guarantor’s Guarantee with respect to the 2029 Notes is secured by such Lien equally and ratably with, or prior to, the Indebtedness secured by such Lien.
Target identity evidence: **THIS EIGHTEENTH SUPPLEMENTAL INDENTURE** (this “**Supplemental Indenture**”), by and among Cencora, Inc., a Delaware corporation (hereinafter called the “**Company**”), and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), a national banking association organized and existing under the laws of the United States of America, as trustee (hereinafter called the “**Trustee**”), is made and entered into as of this 13th day of February, 2026.
Target identity evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its “3.950% Senior Notes due 2029” (the “**2029 Notes**”), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Target identity evidence: The Company has heretofore executed and delivered to the Trustee an indenture, dated as of November 19, 2009 (as such indenture has been amended, supplemented or otherwise modified prior to the date hereof, the “**Base Indenture**”), providing for the issuance of the Company’s unsecured debentures, notes, bonds, and other evidences of indebtedness, to be issued in one or more fully registered series (the “**Securities**”).
Target scope evidence: In addition to the covenants set forth in Article 10 of the Base Indenture, the following additional covenants shall apply with respect to the 2029 Notes.
Section 5.04(a) · Offer to Repurchase Upon Change of Control Triggering Event(a) Upon the occurrence of a Change of Control Triggering Event, unless the Company has exercised its right to redeem the 2029 Notes as described in Section 7.01 hereof within 60 days after the Change of Control Triggering Event, each Holder shall have the right to require the Company to purchase all or a portion (equal to $1,000 or an integral multiple thereof) of such Holder’s 2029 Notes pursuant to the offer described below (the “**Change of Control Offer**”), at a purchase price equal to 101% of the…SpringingTrigger: Upon the occurrence of a Change of Control Triggering Event, unless the Company has exercised its right to redeem the 2029 Notes as described in Section 7.01 hereof within 60 days after the Change of Control Triggering EventSection 5.04. *Offer to Repurchase Upon Change of Control Triggering Event.*Full wording and supporting evidence
Source evidence: (a) Upon the occurrence of a Change of Control Triggering Event, unless the Company has exercised its right to redeem the 2029 Notes as described in Section 7.01 hereof within 60 days after the Change of Control Triggering Event, each Holder shall have the right to require the Company to purchase all or a portion (equal to $1,000 or an integral multiple thereof) of such Holder’s 2029 Notes pursuant to the offer described below (the “**Change of Control Offer**”), at a purchase price equal to 101% of the principal amount thereof plus accrued and unpaid interest, if any, to the date of purchase (the “**Change of Control Payment**”), subject to the rights of the Holders of the 2029 Notes on the relevant Record Date to receive interest due on the relevant Interest Payment Date.
Target identity evidence: **THIS EIGHTEENTH SUPPLEMENTAL INDENTURE** (this “**Supplemental Indenture**”), by and among Cencora, Inc., a Delaware corporation (hereinafter called the “**Company**”), and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), a national banking association organized and existing under the laws of the United States of America, as trustee (hereinafter called the “**Trustee**”), is made and entered into as of this 13th day of February, 2026.
Target identity evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its “3.950% Senior Notes due 2029” (the “**2029 Notes**”), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Target identity evidence: The Company has heretofore executed and delivered to the Trustee an indenture, dated as of November 19, 2009 (as such indenture has been amended, supplemented or otherwise modified prior to the date hereof, the “**Base Indenture**”), providing for the issuance of the Company’s unsecured debentures, notes, bonds, and other evidences of indebtedness, to be issued in one or more fully registered series (the “**Securities**”).
Target scope evidence: In addition to the covenants set forth in Article 10 of the Base Indenture, the following additional covenants shall apply with respect to the 2029 Notes.
Section 3.01(f) · failure by the Company or any of its Restricted Subsidiaries(f) failure by the Company or any of its Restricted Subsidiaries to comply with Section 5.04, and continuance of such default for a period of 30 days after there has been given, by registered or certified mail, to the Company by the Trustee or to the Company and the Trustee by the Holders of at least 25% in principal amount of the 2029 Notes of a Notice of Default;Section 3.01. Events of Default.Full wording and supporting evidence
Source evidence: (f) failure by the Company or any of its Restricted Subsidiaries to comply with Section 5.04, and continuance of such default for a period of 30 days after there has been given, by registered or certified mail, to the Company by the Trustee or to the Company and the Trustee by the Holders of at least 25% in principal amount of the 2029 Notes of a Notice of Default;
Target identity evidence: **Dated as of February 13, 2026**
Target identity evidence: **Dated as of November 19, 2009**
Target identity evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its "3.950% Senior Notes due 2029" (the "2029 Notes"), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Target identity evidence: The 2029 Notes are hereby authorized and designated as the "3.950% Senior Notes due 2029."
Target identity evidence: The Company has heretofore executed and delivered to the Trustee an indenture, dated as of November 19, 2009 (as such indenture has been amended, supplemented or otherwise modified prior to the date hereof, the "Base Indenture")
Section 3.01(j) · to the extent that any Guarantee with respect to the 2029 Notes is provided(j) to the extent that any Guarantee with respect to the 2029 Notes is provided pursuant to Section 5.05 of this Supplemental Indenture, except as permitted by this Supplemental Indenture, any such Guarantee is held in any judicial proceeding to be unenforceable or invalid or shall cease for any reason to be in full force and effect or any Guarantor, or any Person acting on behalf of any Guarantor, shall deny or disaffirm its obligations under such Guarantee.Section 3.01. Events of Default.Full wording and supporting evidence
Source evidence: (j) to the extent that any Guarantee with respect to the 2029 Notes is provided pursuant to Section 5.05 of this Supplemental Indenture, except as permitted by this Supplemental Indenture, any such Guarantee is held in any judicial proceeding to be unenforceable or invalid or shall cease for any reason to be in full force and effect or any Guarantor, or any Person acting on behalf of any Guarantor, shall deny or disaffirm its obligations under such Guarantee.
Target identity evidence: **Dated as of February 13, 2026**
Target identity evidence: **Dated as of November 19, 2009**
Target identity evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its "3.950% Senior Notes due 2029" (the "2029 Notes"), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Target identity evidence: The 2029 Notes are hereby authorized and designated as the "3.950% Senior Notes due 2029."
Target identity evidence: The Company has heretofore executed and delivered to the Trustee an indenture, dated as of November 19, 2009 (as such indenture has been amended, supplemented or otherwise modified prior to the date hereof, the "Base Indenture")
Section 3.01(a) · default in the payment of any interestdefault in the payment of any interest on the 2029 Notes when it becomes due and payable, and continuance of such default for a period of 30 daysSection 3.01. Events of Default.Full wording and supporting evidence
Source evidence: (a) default in the payment of any interest on the 2029 Notes when it becomes due and payable, and continuance of such default for a period of 30 days;
Target identity evidence: **Dated as of February 13, 2026**
Target identity evidence: **Dated as of November 19, 2009**
Target identity evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its "3.950% Senior Notes due 2029" (the "2029 Notes"), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Target identity evidence: The 2029 Notes are hereby authorized and designated as the "3.950% Senior Notes due 2029."
Target identity evidence: The Company has heretofore executed and delivered to the Trustee an indenture, dated as of November 19, 2009 (as such indenture has been amended, supplemented or otherwise modified prior to the date hereof, the "Base Indenture")
Section 3.01(b) · default in the payment of the principal amountdefault in the payment of the principal amount of (or premium, if any, on) the 2029 Notes as and when the same shall become due, either at Stated Maturity, upon redemption, by declaration, or otherwiseSection 3.01. Events of Default.Full wording and supporting evidence
Source evidence: (b) default in the payment of the principal amount of (or premium, if any, on) the 2029 Notes as and when the same shall become due, either at Stated Maturity, upon redemption, by declaration, or otherwise;
Target identity evidence: **Dated as of February 13, 2026**
Target identity evidence: **Dated as of November 19, 2009**
Target identity evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its "3.950% Senior Notes due 2029" (the "2029 Notes"), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Target identity evidence: The 2029 Notes are hereby authorized and designated as the "3.950% Senior Notes due 2029."
Target identity evidence: The Company has heretofore executed and delivered to the Trustee an indenture, dated as of November 19, 2009 (as such indenture has been amended, supplemented or otherwise modified prior to the date hereof, the "Base Indenture")
Section 5.05 · 2029 Note Guarantees**Section 5.05. *2029 Note Guarantees.*** The Company covenants that any Domestic Subsidiary of the Company (other than Blanco or any Receivables Subsidiary) which incurs, has outstanding or guarantees any Specified Indebtedness shall, simultaneously with such incurrence or guarantee (or, if the Domestic Subsidiary has outstanding or guarantees Specified Indebtedness at the time of its creation or acquisition, at the time of such creation or acquisition) shall become a Guarantor and execute and deliver to…Exceptions: Except for all Subsidiaries that have properly been designated as Unrestricted Subsidiaries or Designated Non-Guarantors in accordance with this Supplemental Indenture for so long as they continue to constitute Unrestricted Subsidiaries or Designated Non-Guarantors.Section 5.05. *2029 Note Guarantees.*Full wording and supporting evidence
Source evidence: **Section 5.05. *2029 Note Guarantees.*** The Company covenants that any Domestic Subsidiary of the Company (other than Blanco or any Receivables Subsidiary) which incurs, has outstanding or guarantees any Specified Indebtedness shall, simultaneously with such incurrence or guarantee (or, if the Domestic Subsidiary has outstanding or guarantees Specified Indebtedness at the time of its creation or acquisition, at the time of such creation or acquisition) shall become a Guarantor and execute and deliver to the Trustee a joinder to this Supplemental Indenture pursuant to which such Subsidiary shall agree to guarantee the Company’s obligations under the 2029 Notes, except for all Subsidiaries that have properly been designated as Unrestricted Subsidiaries or Designated Non-Guarantors in accordance with this Supplemental Indenture for so long as they continue to constitute Unrestricted Subsidiaries or Designated Non-Guarantors.
Target identity evidence: **THIS EIGHTEENTH SUPPLEMENTAL INDENTURE** (this “**Supplemental Indenture**”), by and among Cencora, Inc., a Delaware corporation (hereinafter called the “**Company**”), and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), a national banking association organized and existing under the laws of the United States of America, as trustee (hereinafter called the “**Trustee**”), is made and entered into as of this 13th day of February, 2026.
Target identity evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its “3.950% Senior Notes due 2029” (the “**2029 Notes**”), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Target identity evidence: The Company has heretofore executed and delivered to the Trustee an indenture, dated as of November 19, 2009 (as such indenture has been amended, supplemented or otherwise modified prior to the date hereof, the “**Base Indenture**”), providing for the issuance of the Company’s unsecured debentures, notes, bonds, and other evidences of indebtedness, to be issued in one or more fully registered series (the “**Securities**”).
Target scope evidence: In addition to the covenants set forth in Article 10 of the Base Indenture, the following additional covenants shall apply with respect to the 2029 Notes.
Section 5.06 · Designation of Restricted and Unrestricted SubsidiariesThe Board of Directors of the Company may designate any Restricted Subsidiary to be an Unrestricted Subsidiary if that designation would not cause a Default. The Board of Directors of the Company may redesignate any Unrestricted Subsidiary to be a Restricted Subsidiary if the redesignation would not cause a Default.Section 5.06. *Designation of Restricted and Unrestricted Subsidiaries.*Full wording and supporting evidence
Source evidence: **Section 5.06. *Designation of Restricted and Unrestricted Subsidiaries.*** The Board of Directors of the Company may designate any Restricted Subsidiary to be an Unrestricted Subsidiary if that designation would not cause a Default. The Board of Directors of the Company may redesignate any Unrestricted Subsidiary to be a Restricted Subsidiary if the redesignation would not cause a Default.
Target identity evidence: **THIS EIGHTEENTH SUPPLEMENTAL INDENTURE** (this “**Supplemental Indenture**”), by and among Cencora, Inc., a Delaware corporation (hereinafter called the “**Company**”), and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), a national banking association organized and existing under the laws of the United States of America, as trustee (hereinafter called the “**Trustee**”), is made and entered into as of this 13th day of February, 2026.
Target identity evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its “3.950% Senior Notes due 2029” (the “**2029 Notes**”), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Target identity evidence: The Company has heretofore executed and delivered to the Trustee an indenture, dated as of November 19, 2009 (as such indenture has been amended, supplemented or otherwise modified prior to the date hereof, the “**Base Indenture**”), providing for the issuance of the Company’s unsecured debentures, notes, bonds, and other evidences of indebtedness, to be issued in one or more fully registered series (the “**Securities**”).
Target scope evidence: In addition to the covenants set forth in Article 10 of the Base Indenture, the following additional covenants shall apply with respect to the 2029 Notes.
Section 5.03 · Limitation on Sale and Leaseback TransactionsThe Company will not, and will not permit any of its Restricted Subsidiaries to, enter into any sale and leaseback transactionSection 5.03. *Limitation on Sale and Leaseback Transactions.*Full wording and supporting evidence
Source evidence: **Section 5.03. *Limitation on Sale and Leaseback Transactions.*** The Company will not, and will not permit any of its Restricted Subsidiaries to, enter into any sale and leaseback transaction; *provided* that the Company or any Guarantor may enter into a sale and leaseback transaction if (i) the Company or such Guarantor, as applicable, could have incurred a Lien to secure such Indebtedness in an amount equal to the Attributable Indebtedness relating to such sale and leaseback transaction pursuant to the provisions of Section 5.02 hereof and (ii) the gross cash proceeds of such sale and leaseback transaction are at least equal to the fair market value (as determined in good faith by the Board of Directors of the Company and set forth in an Officers’ Certificate delivered to the Trustee) of the property that is the subject of such sale and leaseback transaction.
Target identity evidence: **THIS EIGHTEENTH SUPPLEMENTAL INDENTURE** (this “**Supplemental Indenture**”), by and among Cencora, Inc., a Delaware corporation (hereinafter called the “**Company**”), and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), a national banking association organized and existing under the laws of the United States of America, as trustee (hereinafter called the “**Trustee**”), is made and entered into as of this 13th day of February, 2026.
Target identity evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its “3.950% Senior Notes due 2029” (the “**2029 Notes**”), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Target identity evidence: The Company has heretofore executed and delivered to the Trustee an indenture, dated as of November 19, 2009 (as such indenture has been amended, supplemented or otherwise modified prior to the date hereof, the “**Base Indenture**”), providing for the issuance of the Company’s unsecured debentures, notes, bonds, and other evidences of indebtedness, to be issued in one or more fully registered series (the “**Securities**”).
Target scope evidence: In addition to the covenants set forth in Article 10 of the Base Indenture, the following additional covenants shall apply with respect to the 2029 Notes.
The Company has heretofore executed and delivered to the Trustee an indenture (the “**Base Indenture**”), dated as of November 19, 2009, between the Company and the Trustee, as such indenture has been amended, supplemented or otherwise modified prior to February 13, 2026 and, as amended and supplemented by an Eighteenth supplemental indenture thereto (the “**Eighteenth Supplemental Indenture**” and, together with the Base Indenture, the “**Indenture**”), dated as of February 13, 2026, among the Company and the Trustee, providing for the original issuance of an aggregate principal amount of $500 million ($500,000,000) of the Company’s 3.950% Senior Notes due 2029 (the “**2029 Notes**”).
Issuer evidence: This JOINDER TO EIGHTEENTH SUPPLEMENTAL INDENTURE (this “**Joinder**”), dated as of \_\_\_\_\_\_\_\_\_\_\_\_\_, 20\_\_, among \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ (the “**Guarantor[s]**”), [each] a subsidiary of Cencora, Inc. (or [its/their] permitted successor[s]), a Delaware corporation (the “**Company**”), the Company and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee under the Eighteenth Supplemental Indenture referred to below (the “**Trustee**”).
Supporting evidence: The Company has heretofore executed and delivered to the Trustee an indenture (the “**Base Indenture**”), dated as of November 19, 2009, between the Company and the Trustee, as such indenture has been amended, supplemented or otherwise modified prior to February 13, 2026 and, as amended and supplemented by an Eighteenth supplemental indenture thereto (the “**Eighteenth Supplemental Indenture**” and, together with the Base Indenture, the “**Indenture**”), dated as of February 13, 2026, among the Company and the Trustee, providing for the original issuance of an aggregate principal amount of $500 million ($500,000,000) of the Company’s 3.950% Senior Notes due 2029 (the “**2029 Notes**”).
Supporting evidence: The Company has heretofore executed and delivered to the Trustee an indenture (the “**Base Indenture**”), dated as of November 19, 2009, between the Company and the Trustee, as such indenture has been amended, supplemented or otherwise modified prior to February 13, 2026 and, as amended and supplemented by an Eighteenth supplemental indenture thereto (the “**Eighteenth Supplemental Indenture**” and, together with the Base Indenture, the “**Indenture**”), dated as of February 13, 2026, among the Company and the Trustee, providing for the original issuance of an aggregate principal amount of $500 million ($500,000,000) of the Company’s 3.950% Senior Notes due 2029 (the “**2029 Notes**”).
3.950% Senior Notes due 2029
Note · Cencora, Inc.
Reference: 3.950% Senior Notes due 2029
Active
Original principal
USD 500,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
—
Last reported interest terms:
3.95%
Reported 2026-02-11Later filings may not restate these terms; this does not confirm they still apply.
Covenant terms for this agreement are not yet verified.
On February 10, 2026, Cencora, Inc. (the “Company” or “Cencora”) issued a news release announcing that it priced $500,000,000 aggregate principal amount of the Company’s 3.950% Senior Notes due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.250% Senior Notes due 2030 (the “2030 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.600% Senior Notes due 2033 (the “2033 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 4.900% Senior Notes due 2036 (the “2036 Notes”) and $500,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes” and, together with the 2029 Notes, the 2030 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in an underwritten registered public offering. The news release is being furnished with this Current Report as Exhibit 99.1 and is incorporated herein by reference.
Issuer evidence: On February 10, 2026, Cencora, Inc. (the “Company” or “Cencora”) issued a news release announcing that it priced $500,000,000 aggregate principal amount of the Company’s 3.950% Senior Notes due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.250% Senior Notes due 2030 (the “2030 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.600% Senior Notes due 2033 (the “2033 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 4.900% Senior Notes due 2036 (the “2036 Notes”) and $500,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes” and, together with the 2029 Notes, the 2030 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in an underwritten registered public offering.
Supporting evidence: On February 10, 2026, Cencora, Inc. (the “Company” or “Cencora”) issued a news release announcing that it priced $500,000,000 aggregate principal amount of the Company’s 3.950% Senior Notes due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.250% Senior Notes due 2030 (the “2030 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.600% Senior Notes due 2033 (the “2033 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 4.900% Senior Notes due 2036 (the “2036 Notes”) and $500,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes” and, together with the 2029 Notes, the 2030 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in an underwritten registered public offering. The news release is being furnished with this Current Report as Exhibit 99.1 and is incorporated herein by reference.
Supporting evidence: On February 10, 2026, Cencora, Inc. (the “Company” or “Cencora”) issued a news release announcing that it priced $500,000,000 aggregate principal amount of the Company’s 3.950% Senior Notes due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.250% Senior Notes due 2030 (the “2030 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.600% Senior Notes due 2033 (the “2033 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 4.900% Senior Notes due 2036 (the “2036 Notes”) and $500,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes” and, together with the 2029 Notes, the 2030 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in an underwritten registered public offering. The news release is being furnished with this Current Report as Exhibit 99.1 and is incorporated herein by reference.
4.250% Senior Notes due 2030
Note · Cencora, Inc.
Reference: 4.250% Senior Notes due 2030
Active
Original principal
USD 500,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
—
Last reported interest terms:
4.25%
Reported 2026-02-11Later filings may not restate these terms; this does not confirm they still apply.
Covenant terms for this agreement are not yet verified.
On February 10, 2026, Cencora, Inc. (the “Company” or “Cencora”) issued a news release announcing that it priced $500,000,000 aggregate principal amount of the Company’s 3.950% Senior Notes due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.250% Senior Notes due 2030 (the “2030 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.600% Senior Notes due 2033 (the “2033 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 4.900% Senior Notes due 2036 (the “2036 Notes”) and $500,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes” and, together with the 2029 Notes, the 2030 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in an underwritten registered public offering. The news release is being furnished with this Current Report as Exhibit 99.1 and is incorporated herein by reference.
Issuer evidence: On February 10, 2026, Cencora, Inc. (the “Company” or “Cencora”) issued a news release announcing that it priced $500,000,000 aggregate principal amount of the Company’s 3.950% Senior Notes due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.250% Senior Notes due 2030 (the “2030 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.600% Senior Notes due 2033 (the “2033 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 4.900% Senior Notes due 2036 (the “2036 Notes”) and $500,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes” and, together with the 2029 Notes, the 2030 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in an underwritten registered public offering.
Supporting evidence: On February 10, 2026, Cencora, Inc. (the “Company” or “Cencora”) issued a news release announcing that it priced $500,000,000 aggregate principal amount of the Company’s 3.950% Senior Notes due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.250% Senior Notes due 2030 (the “2030 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.600% Senior Notes due 2033 (the “2033 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 4.900% Senior Notes due 2036 (the “2036 Notes”) and $500,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes” and, together with the 2029 Notes, the 2030 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in an underwritten registered public offering. The news release is being furnished with this Current Report as Exhibit 99.1 and is incorporated herein by reference.
Supporting evidence: On February 10, 2026, Cencora, Inc. (the “Company” or “Cencora”) issued a news release announcing that it priced $500,000,000 aggregate principal amount of the Company’s 3.950% Senior Notes due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.250% Senior Notes due 2030 (the “2030 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.600% Senior Notes due 2033 (the “2033 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 4.900% Senior Notes due 2036 (the “2036 Notes”) and $500,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes” and, together with the 2029 Notes, the 2030 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in an underwritten registered public offering. The news release is being furnished with this Current Report as Exhibit 99.1 and is incorporated herein by reference.
4.600% Senior Notes due 2033
Note · Cencora, Inc.
Reference: 4.600% Senior Notes due 2033
Active
Original principal
USD 500,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
—
Last reported interest terms:
4.6%
Reported 2026-02-11Later filings may not restate these terms; this does not confirm they still apply.
Covenant terms for this agreement are not yet verified.
On February 10, 2026, Cencora, Inc. (the “Company” or “Cencora”) issued a news release announcing that it priced $500,000,000 aggregate principal amount of the Company’s 3.950% Senior Notes due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.250% Senior Notes due 2030 (the “2030 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.600% Senior Notes due 2033 (the “2033 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 4.900% Senior Notes due 2036 (the “2036 Notes”) and $500,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes” and, together with the 2029 Notes, the 2030 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in an underwritten registered public offering. The news release is being furnished with this Current Report as Exhibit 99.1 and is incorporated herein by reference.
Issuer evidence: On February 10, 2026, Cencora, Inc. (the “Company” or “Cencora”) issued a news release announcing that it priced $500,000,000 aggregate principal amount of the Company’s 3.950% Senior Notes due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.250% Senior Notes due 2030 (the “2030 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.600% Senior Notes due 2033 (the “2033 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 4.900% Senior Notes due 2036 (the “2036 Notes”) and $500,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes” and, together with the 2029 Notes, the 2030 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in an underwritten registered public offering.
Supporting evidence: On February 10, 2026, Cencora, Inc. (the “Company” or “Cencora”) issued a news release announcing that it priced $500,000,000 aggregate principal amount of the Company’s 3.950% Senior Notes due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.250% Senior Notes due 2030 (the “2030 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.600% Senior Notes due 2033 (the “2033 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 4.900% Senior Notes due 2036 (the “2036 Notes”) and $500,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes” and, together with the 2029 Notes, the 2030 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in an underwritten registered public offering. The news release is being furnished with this Current Report as Exhibit 99.1 and is incorporated herein by reference.
Supporting evidence: On February 10, 2026, Cencora, Inc. (the “Company” or “Cencora”) issued a news release announcing that it priced $500,000,000 aggregate principal amount of the Company’s 3.950% Senior Notes due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.250% Senior Notes due 2030 (the “2030 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.600% Senior Notes due 2033 (the “2033 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 4.900% Senior Notes due 2036 (the “2036 Notes”) and $500,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes” and, together with the 2029 Notes, the 2030 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in an underwritten registered public offering. The news release is being furnished with this Current Report as Exhibit 99.1 and is incorporated herein by reference.
4.900% Senior Notes due 2036
Note · Cencora, Inc.
Reference: 4.900% Senior Notes due 2036
Active
Original principal
USD 1,000,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
—
Last reported interest terms:
4.9%
Reported 2026-02-13Later filings may not restate these terms; this does not confirm they still apply.
Verified covenant terms
Section 5.02 · LiensSection 5.02. Liens. The Company will not, and will not permit any of its Restricted Subsidiaries to, directly or indirectly, create, incur, assume or suffer to exist any Lien of any kind securing Indebtedness on any asset now owned or hereafter acquired, except Permitted Liens, unless (a) in the case of the Company, the 2036 Notes are secured by such Lien equally and ratably with, or prior to, the Indebtedness secured by such Lien or (b) in the case of any Guarantor, such Guarantor’s Guarantee with…Section 5.02. Liens.Full wording and supporting evidence
Source evidence: Section 5.02. Liens. The Company will not, and will not permit any of its Restricted Subsidiaries to, directly or indirectly, create, incur, assume or suffer to exist any Lien of any kind securing Indebtedness on any asset now owned or hereafter acquired, except Permitted Liens, unless (a) in the case of the Company, the 2036 Notes are secured by such Lien equally and ratably with, or prior to, the Indebtedness secured by such Lien or (b) in the case of any Guarantor, such Guarantor’s Guarantee with respect to the 2036 Notes is secured by such Lien equally and ratably with, or prior to, the Indebtedness secured by such Lien.
Target identity evidence: The Company has heretofore executed and delivered to the Trustee an indenture, dated as of November 19, 2009 (as such indenture has been amended, supplemented or otherwise modified prior to the date hereof, the “Base Indenture”), providing for the issuance of the Company’s unsecured debentures, notes, bonds, and other evidences of indebtedness, to be issued in one or more fully registered series (the “Securities”).
Target identity evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its “4.900% Senior Notes due 2036” (the “2036 Notes”), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Target identity evidence: 4.900% Senior Notes due 2036
Target scope evidence: In addition to the covenants set forth in Article 10 of the Base Indenture, the following additional covenants shall apply with respect to the 2036 Notes.
Section 5.03 · Limitation on Sale and Leaseback TransactionsSection 5.03. Limitation on Sale and Leaseback Transactions. The Company will not, and will not permit any of its Restricted Subsidiaries to, enter into any sale and leaseback transaction;Section 5.03. Limitation on Sale and Leaseback Transactions.Full wording and supporting evidence
Source evidence: Section 5.03. Limitation on Sale and Leaseback Transactions. The Company will not, and will not permit any of its Restricted Subsidiaries to, enter into any sale and leaseback transaction; provided that the Company or any Guarantor may enter into a sale and leaseback transaction if (i) the Company or such Guarantor, as applicable, could have incurred a Lien to secure such Indebtedness in an amount equal to the Attributable Indebtedness relating to such sale and leaseback transaction pursuant to the provisions of Section 5.02 hereof and (ii) the gross cash proceeds of such sale and leaseback transaction are at least equal to the fair market value (as determined in good faith by the Board of Directors of the Company and set forth in an Officers’ Certificate delivered to the Trustee) of the property that is the subject of such sale and leaseback transaction.
Target identity evidence: The Company has heretofore executed and delivered to the Trustee an indenture, dated as of November 19, 2009 (as such indenture has been amended, supplemented or otherwise modified prior to the date hereof, the “Base Indenture”), providing for the issuance of the Company’s unsecured debentures, notes, bonds, and other evidences of indebtedness, to be issued in one or more fully registered series (the “Securities”).
Target identity evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its “4.900% Senior Notes due 2036” (the “2036 Notes”), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Target identity evidence: 4.900% Senior Notes due 2036
Target scope evidence: In addition to the covenants set forth in Article 10 of the Base Indenture, the following additional covenants shall apply with respect to the 2036 Notes.
Section 5.04(a) · Offer to Repurchase Upon Change of Control Triggering Event(a) Upon the occurrence of a Change of Control Triggering Event, unless the Company has exercised its right to redeem the 2036 Notes as described in Section 7.01 hereof within 60 days after the Change of Control Triggering Event, each Holder shall have the right to require the Company to purchase all or a portion (equal to $1,000 or an integral multiple thereof) of such Holder’s 2036 Notes pursuant to the offer described below (the “Change of Control Offer”), at a purchase price equal to 101% of the…SpringingTrigger: Upon the occurrence of a Change of Control Triggering EventSection 5.04. Offer to Repurchase Upon Change of Control Triggering Event.Full wording and supporting evidence
Source evidence: (a) Upon the occurrence of a Change of Control Triggering Event, unless the Company has exercised its right to redeem the 2036 Notes as described in Section 7.01 hereof within 60 days after the Change of Control Triggering Event, each Holder shall have the right to require the Company to purchase all or a portion (equal to $1,000 or an integral multiple thereof) of such Holder’s 2036 Notes pursuant to the offer described below (the “Change of Control Offer”), at a purchase price equal to 101% of the principal amount thereof plus accrued and unpaid interest, if any, to the date of purchase (the “Change of Control Payment”), subject to the rights of the Holders of the 2036 Notes on the relevant Record Date to receive interest due on the relevant Interest Payment Date.
Target identity evidence: The Company has heretofore executed and delivered to the Trustee an indenture, dated as of November 19, 2009 (as such indenture has been amended, supplemented or otherwise modified prior to the date hereof, the “Base Indenture”), providing for the issuance of the Company’s unsecured debentures, notes, bonds, and other evidences of indebtedness, to be issued in one or more fully registered series (the “Securities”).
Target identity evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its “4.900% Senior Notes due 2036” (the “2036 Notes”), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Target identity evidence: 4.900% Senior Notes due 2036
Target scope evidence: In addition to the covenants set forth in Article 10 of the Base Indenture, the following additional covenants shall apply with respect to the 2036 Notes.
Section 5.05 · 2036 Note GuaranteesSection 5.05. 2036 Note Guarantees. The Company covenants that any Domestic Subsidiary of the Company (other than Blanco or any Receivables Subsidiary) which incurs, has outstanding or guarantees any Specified Indebtedness shall, simultaneously with such incurrence or guarantee (or, if the Domestic Subsidiary has outstanding or guarantees Specified Indebtedness at the time of its creation or acquisition, at the time of such creation or acquisition) shall become a Guarantor and execute and deliver to the…Section 5.05. 2036 Note Guarantees.Full wording and supporting evidence
Source evidence: Section 5.05. 2036 Note Guarantees. The Company covenants that any Domestic Subsidiary of the Company (other than Blanco or any Receivables Subsidiary) which incurs, has outstanding or guarantees any Specified Indebtedness shall, simultaneously with such incurrence or guarantee (or, if the Domestic Subsidiary has outstanding or guarantees Specified Indebtedness at the time of its creation or acquisition, at the time of such creation or acquisition) shall become a Guarantor and execute and deliver to the Trustee a joinder to this Supplemental Indenture pursuant to which such Subsidiary shall agree to guarantee the Company’s obligations under the 2036 Notes, except for all Subsidiaries that have properly been designated as Unrestricted Subsidiaries or Designated Non-Guarantors in accordance with this Supplemental Indenture for so long as they continue to constitute Unrestricted Subsidiaries or Designated Non-Guarantors.
Target identity evidence: The Company has heretofore executed and delivered to the Trustee an indenture, dated as of November 19, 2009 (as such indenture has been amended, supplemented or otherwise modified prior to the date hereof, the “Base Indenture”), providing for the issuance of the Company’s unsecured debentures, notes, bonds, and other evidences of indebtedness, to be issued in one or more fully registered series (the “Securities”).
Target identity evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its “4.900% Senior Notes due 2036” (the “2036 Notes”), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Target identity evidence: 4.900% Senior Notes due 2036
Target scope evidence: In addition to the covenants set forth in Article 10 of the Base Indenture, the following additional covenants shall apply with respect to the 2036 Notes.
Section 5.06 · Designation of Restricted and Unrestricted SubsidiariesThe Board of Directors of the Company may designate any Restricted Subsidiary to be an Unrestricted Subsidiary if that designation would not cause a Default.Section 5.06. Designation of Restricted and Unrestricted Subsidiaries.Full wording and supporting evidence
Source evidence: Section 5.06. Designation of Restricted and Unrestricted Subsidiaries. The Board of Directors of the Company may designate any Restricted Subsidiary to be an Unrestricted Subsidiary if that designation would not cause a Default.
Target identity evidence: The Company has heretofore executed and delivered to the Trustee an indenture, dated as of November 19, 2009 (as such indenture has been amended, supplemented or otherwise modified prior to the date hereof, the “Base Indenture”), providing for the issuance of the Company’s unsecured debentures, notes, bonds, and other evidences of indebtedness, to be issued in one or more fully registered series (the “Securities”).
Target identity evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its “4.900% Senior Notes due 2036” (the “2036 Notes”), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Target identity evidence: 4.900% Senior Notes due 2036
Target scope evidence: In addition to the covenants set forth in Article 10 of the Base Indenture, the following additional covenants shall apply with respect to the 2036 Notes.
“Initial 2036 Notes” means the first $1,000,000,000 aggregate principal amount of the 2036 Notes issued under this Supplemental Indenture on the date hereof.
Issuer evidence: THIS TWENTY-FIRST SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), by and among Cencora, Inc., a Delaware corporation (hereinafter called the “Company”), and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), a national banking association organized and existing under the laws of the United States of America, as trustee (hereinafter called the “Trustee”), is made and entered into as of this 13^th^ day of February, 2026.
Supporting evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its “4.900% Senior Notes due 2036” (the “2036 Notes”), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Supporting evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its “4.900% Senior Notes due 2036” (the “2036 Notes”), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Supporting evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its “4.900% Senior Notes due 2036” (the “2036 Notes”), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
4.900% Senior Notes due 2036
Note · Cencora, Inc.
Reference: 4.900% Senior Notes due 2036
Active
Original principal
USD 1,000,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
—
Last reported interest terms:
4.9%
Reported 2026-02-11Later filings may not restate these terms; this does not confirm they still apply.
Covenant terms for this agreement are not yet verified.
On February 10, 2026, Cencora, Inc. (the “Company” or “Cencora”) issued a news release announcing that it priced $500,000,000 aggregate principal amount of the Company’s 3.950% Senior Notes due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.250% Senior Notes due 2030 (the “2030 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.600% Senior Notes due 2033 (the “2033 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 4.900% Senior Notes due 2036 (the “2036 Notes”) and $500,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes” and, together with the 2029 Notes, the 2030 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in an underwritten registered public offering. The news release is being furnished with this Current Report as Exhibit 99.1 and is incorporated herein by reference.
Issuer evidence: On February 10, 2026, Cencora, Inc. (the “Company” or “Cencora”) issued a news release announcing that it priced $500,000,000 aggregate principal amount of the Company’s 3.950% Senior Notes due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.250% Senior Notes due 2030 (the “2030 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.600% Senior Notes due 2033 (the “2033 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 4.900% Senior Notes due 2036 (the “2036 Notes”) and $500,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes” and, together with the 2029 Notes, the 2030 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in an underwritten registered public offering.
Supporting evidence: On February 10, 2026, Cencora, Inc. (the “Company” or “Cencora”) issued a news release announcing that it priced $500,000,000 aggregate principal amount of the Company’s 3.950% Senior Notes due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.250% Senior Notes due 2030 (the “2030 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.600% Senior Notes due 2033 (the “2033 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 4.900% Senior Notes due 2036 (the “2036 Notes”) and $500,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes” and, together with the 2029 Notes, the 2030 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in an underwritten registered public offering. The news release is being furnished with this Current Report as Exhibit 99.1 and is incorporated herein by reference.
Supporting evidence: On February 10, 2026, Cencora, Inc. (the “Company” or “Cencora”) issued a news release announcing that it priced $500,000,000 aggregate principal amount of the Company’s 3.950% Senior Notes due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.250% Senior Notes due 2030 (the “2030 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.600% Senior Notes due 2033 (the “2033 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 4.900% Senior Notes due 2036 (the “2036 Notes”) and $500,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes” and, together with the 2029 Notes, the 2030 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in an underwritten registered public offering. The news release is being furnished with this Current Report as Exhibit 99.1 and is incorporated herein by reference.
5.650% Senior Notes due 2056
Note · Cencora, Inc.
Reference: 5.650% Senior Notes due 2056
Active
Original principal
USD 500,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
—
Last reported interest terms:
5.65%
Reported 2026-02-11Later filings may not restate these terms; this does not confirm they still apply.
Covenant terms for this agreement are not yet verified.
On February 10, 2026, Cencora, Inc. (the “Company” or “Cencora”) issued a news release announcing that it priced $500,000,000 aggregate principal amount of the Company’s 3.950% Senior Notes due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.250% Senior Notes due 2030 (the “2030 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.600% Senior Notes due 2033 (the “2033 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 4.900% Senior Notes due 2036 (the “2036 Notes”) and $500,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes” and, together with the 2029 Notes, the 2030 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in an underwritten registered public offering. The news release is being furnished with this Current Report as Exhibit 99.1 and is incorporated herein by reference.
Issuer evidence: On February 10, 2026, Cencora, Inc. (the “Company” or “Cencora”) issued a news release announcing that it priced $500,000,000 aggregate principal amount of the Company’s 3.950% Senior Notes due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.250% Senior Notes due 2030 (the “2030 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.600% Senior Notes due 2033 (the “2033 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 4.900% Senior Notes due 2036 (the “2036 Notes”) and $500,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes” and, together with the 2029 Notes, the 2030 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in an underwritten registered public offering.
Supporting evidence: On February 10, 2026, Cencora, Inc. (the “Company” or “Cencora”) issued a news release announcing that it priced $500,000,000 aggregate principal amount of the Company’s 3.950% Senior Notes due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.250% Senior Notes due 2030 (the “2030 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.600% Senior Notes due 2033 (the “2033 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 4.900% Senior Notes due 2036 (the “2036 Notes”) and $500,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes” and, together with the 2029 Notes, the 2030 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in an underwritten registered public offering. The news release is being furnished with this Current Report as Exhibit 99.1 and is incorporated herein by reference.
Supporting evidence: On February 10, 2026, Cencora, Inc. (the “Company” or “Cencora”) issued a news release announcing that it priced $500,000,000 aggregate principal amount of the Company’s 3.950% Senior Notes due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.250% Senior Notes due 2030 (the “2030 Notes”), $500,000,000 aggregate principal amount of the Company’s 4.600% Senior Notes due 2033 (the “2033 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 4.900% Senior Notes due 2036 (the “2036 Notes”) and $500,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes” and, together with the 2029 Notes, the 2030 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in an underwritten registered public offering. The news release is being furnished with this Current Report as Exhibit 99.1 and is incorporated herein by reference.
5.650% Senior Notes due 2056
Note · Cencora, Inc.
Reference: 5.650% Senior Notes due 2056
Active
Original principal
USD 500,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
—
Last reported interest terms:
5.65%
Reported 2026-02-13Later filings may not restate these terms; this does not confirm they still apply.
Verified covenant terms
Section 5.02 · LiensThe Company will not, and will not permit any of its Restricted Subsidiaries to, directly or indirectly, create, incur, assume or suffer to exist any Lien of any kind securing Indebtedness on any asset now owned or hereafter acquired, except Permitted LiensExceptions: except Permitted Liens, unless (a) in the case of the Company, the 2056 Notes are secured by such Lien equally and ratably with, or prior to, the Indebtedness secured by such Lien or (b) in the case of any Guarantor, such Guarantor's Guarantee with respect to the 2056 Notes is secured by such Lien equally and ratably with, or prior to, the Indebtedness secured by such LienSection 5.02. Liens.Full wording and supporting evidence
Source evidence: The Company will not, and will not permit any of its Restricted Subsidiaries to, directly or indirectly, create, incur, assume or suffer to exist any Lien of any kind securing Indebtedness on any asset now owned or hereafter acquired, except Permitted Liens, unless (a) in the case of the Company, the 2056 Notes are secured by such Lien equally and ratably with, or prior to, the Indebtedness secured by such Lien or (b) in the case of any Guarantor, such Guarantor's Guarantee with respect to the 2056 Notes is secured by such Lien equally and ratably with, or prior to, the Indebtedness secured by such Lien.
Target identity evidence: THIS TWENTY-SECOND SUPPLEMENTAL INDENTURE (this "Supplemental Indenture"), by and among Cencora, Inc., a Delaware corporation (hereinafter called the "Company"), and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), a national banking association organized and existing under the laws of the United States of America, as trustee (hereinafter called the "Trustee"), is made and entered into as of this 13^th^ day of February, 2026.
Target identity evidence: The Company has heretofore executed and delivered to the Trustee an indenture, dated as of November 19, 2009 (as such indenture has been amended, supplemented or otherwise modified prior to the date hereof, the "Base Indenture"), providing for the issuance of the Company's unsecured debentures, notes, bonds, and other evidences of indebtedness, to be issued in one or more fully registered series (the "Securities").
Target identity evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its "5.650% Senior Notes due 2056" (the "2056 Notes"), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Target scope evidence: In addition to the covenants set forth in Article 10 of the Base Indenture, the following additional covenants shall apply with respect to the 2056 Notes.
Target scope evidence: with respect to the 2056 Notes
Section 5.04 · Offer to Repurchase Upon Change of Control Triggering EventUpon the occurrence of a Change of Control Triggering Event, unless the Company has exercised its right to redeem the 2056 Notes as described in Section 7.01 hereof within 60 days after the Change of Control Triggering Event, each Holder shall have the right to require the Company to purchase all or a portion (equal to $1,000 or an integral multiple thereof) of such Holder's 2056 Notes pursuant to the offer described below (the "Change of Control Offer"), at a purchase price equal to 101% of the principal…SpringingTrigger: Upon the occurrence of a Change of Control Triggering EventSection 5.04. Offer to Repurchase Upon Change of Control Triggering Event.Full wording and supporting evidence
Source evidence: Upon the occurrence of a Change of Control Triggering Event, unless the Company has exercised its right to redeem the 2056 Notes as described in Section 7.01 hereof within 60 days after the Change of Control Triggering Event, each Holder shall have the right to require the Company to purchase all or a portion (equal to $1,000 or an integral multiple thereof) of such Holder's 2056 Notes pursuant to the offer described below (the "Change of Control Offer"), at a purchase price equal to 101% of the principal amount thereof plus accrued and unpaid interest, if any, to the date of purchase (the "Change of Control Payment")
Target identity evidence: THIS TWENTY-SECOND SUPPLEMENTAL INDENTURE (this "Supplemental Indenture"), by and among Cencora, Inc., a Delaware corporation (hereinafter called the "Company"), and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), a national banking association organized and existing under the laws of the United States of America, as trustee (hereinafter called the "Trustee"), is made and entered into as of this 13^th^ day of February, 2026.
Target identity evidence: The Company has heretofore executed and delivered to the Trustee an indenture, dated as of November 19, 2009 (as such indenture has been amended, supplemented or otherwise modified prior to the date hereof, the "Base Indenture"), providing for the issuance of the Company's unsecured debentures, notes, bonds, and other evidences of indebtedness, to be issued in one or more fully registered series (the "Securities").
Target identity evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its "5.650% Senior Notes due 2056" (the "2056 Notes"), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Target scope evidence: In addition to the covenants set forth in Article 10 of the Base Indenture, the following additional covenants shall apply with respect to the 2056 Notes.
Section 3.01(j) · Events of Defaultto the extent that any Guarantee with respect to the 2056 Notes is provided pursuant to Section 5.05 of this Supplemental Indenture, except as permitted by this Supplemental Indenture, any such Guarantee is held in any judicial proceeding to be unenforceable or invalid or shall cease for any reason to be in full force and effect or any Guarantor, or any Person acting on behalf of any Guarantor, shall deny or disaffirm its obligations under such Guarantee.Exceptions: except as permitted by this Supplemental IndentureSection 3.01. Events of Default.Full wording and supporting evidence
Source evidence: to the extent that any Guarantee with respect to the 2056 Notes is provided pursuant to Section 5.05 of this Supplemental Indenture, except as permitted by this Supplemental Indenture, any such Guarantee is held in any judicial proceeding to be unenforceable or invalid or shall cease for any reason to be in full force and effect or any Guarantor, or any Person acting on behalf of any Guarantor, shall deny or disaffirm its obligations under such Guarantee.
Target identity evidence: THIS TWENTY-SECOND SUPPLEMENTAL INDENTURE (this "Supplemental Indenture"), by and among Cencora, Inc., a Delaware corporation (hereinafter called the "Company"), and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), a national banking association organized and existing under the laws of the United States of America, as trustee (hereinafter called the "Trustee"), is made and entered into as of this 13^th^ day of February, 2026.
Target identity evidence: The Company has heretofore executed and delivered to the Trustee an indenture, dated as of November 19, 2009 (as such indenture has been amended, supplemented or otherwise modified prior to the date hereof, the "Base Indenture"), providing for the issuance of the Company's unsecured debentures, notes, bonds, and other evidences of indebtedness, to be issued in one or more fully registered series (the "Securities").
Target identity evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its "5.650% Senior Notes due 2056" (the "2056 Notes"), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Section 5.06 · Designation of Restricted and Unrestricted SubsidiariesThe Board of Directors of the Company may designate any Restricted Subsidiary to be an Unrestricted Subsidiary if that designation would not cause a Default.Section 5.06. Designation of Restricted and Unrestricted Subsidiaries.Full wording and supporting evidence
Source evidence: The Board of Directors of the Company may designate any Restricted Subsidiary to be an Unrestricted Subsidiary if that designation would not cause a Default. The Board of Directors of the Company may redesignate any Unrestricted Subsidiary to be a Restricted Subsidiary if the redesignation would not cause a Default.
Target identity evidence: THIS TWENTY-SECOND SUPPLEMENTAL INDENTURE (this "Supplemental Indenture"), by and among Cencora, Inc., a Delaware corporation (hereinafter called the "Company"), and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), a national banking association organized and existing under the laws of the United States of America, as trustee (hereinafter called the "Trustee"), is made and entered into as of this 13^th^ day of February, 2026.
Target identity evidence: The Company has heretofore executed and delivered to the Trustee an indenture, dated as of November 19, 2009 (as such indenture has been amended, supplemented or otherwise modified prior to the date hereof, the "Base Indenture"), providing for the issuance of the Company's unsecured debentures, notes, bonds, and other evidences of indebtedness, to be issued in one or more fully registered series (the "Securities").
Target identity evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its "5.650% Senior Notes due 2056" (the "2056 Notes"), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Target scope evidence: In addition to the covenants set forth in Article 10 of the Base Indenture, the following additional covenants shall apply with respect to the 2056 Notes.
Section 5.05 · 2056 Note GuaranteesThe Company covenants that any Domestic Subsidiary of the Company (other than Blanco or any Receivables Subsidiary) which incurs, has outstanding or guarantees any Specified Indebtedness shall, simultaneously with such incurrence or guarantee (or, if the Domestic Subsidiary has outstanding or guarantees Specified Indebtedness at the time of its creation or acquisition, at the time of such creation or acquisition) shall become a Guarantor and execute and deliver to the Trustee a joinder to this…SpringingTrigger: any Domestic Subsidiary of the Company (other than Blanco or any Receivables Subsidiary) which incurs, has outstanding or guarantees any Specified IndebtednessSection 5.05. 2056 Note Guarantees.Full wording and supporting evidence
Source evidence: The Company covenants that any Domestic Subsidiary of the Company (other than Blanco or any Receivables Subsidiary) which incurs, has outstanding or guarantees any Specified Indebtedness shall, simultaneously with such incurrence or guarantee (or, if the Domestic Subsidiary has outstanding or guarantees Specified Indebtedness at the time of its creation or acquisition, at the time of such creation or acquisition) shall become a Guarantor and execute and deliver to the Trustee a joinder to this Supplemental Indenture pursuant to which such Subsidiary shall agree to guarantee the Company's obligations under the 2056 Notes, except for all Subsidiaries that have properly been designated as Unrestricted Subsidiaries or Designated Non-Guarantors in accordance with this Supplemental Indenture for so long as they continue to constitute Unrestricted Subsidiaries or Designated Non-Guarantors.
Target identity evidence: THIS TWENTY-SECOND SUPPLEMENTAL INDENTURE (this "Supplemental Indenture"), by and among Cencora, Inc., a Delaware corporation (hereinafter called the "Company"), and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), a national banking association organized and existing under the laws of the United States of America, as trustee (hereinafter called the "Trustee"), is made and entered into as of this 13^th^ day of February, 2026.
Target identity evidence: The Company has heretofore executed and delivered to the Trustee an indenture, dated as of November 19, 2009 (as such indenture has been amended, supplemented or otherwise modified prior to the date hereof, the "Base Indenture"), providing for the issuance of the Company's unsecured debentures, notes, bonds, and other evidences of indebtedness, to be issued in one or more fully registered series (the "Securities").
Target identity evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its "5.650% Senior Notes due 2056" (the "2056 Notes"), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Target scope evidence: In addition to the covenants set forth in Article 10 of the Base Indenture, the following additional covenants shall apply with respect to the 2056 Notes.
Section 5.03 · Limitation on Sale and Leaseback TransactionsThe Company will not, and will not permit any of its Restricted Subsidiaries to, enter into any sale and leaseback transaction;Exceptions: provided that the Company or any Guarantor may enter into a sale and leaseback transaction if (i) the Company or such Guarantor, as applicable, could have incurred a Lien to secure such Indebtedness in an amount equal to the Attributable Indebtedness relating to such sale and leaseback transaction pursuant to the provisions of Section 5.02 hereof and (ii) the gross cash proceeds of such sale and leaseback transaction are at least equal to the fair market value (as determined in good faith by the Board of Directors of the Company and set forth in an Officers' Certificate delivered to the Trustee) of the property that is the subject of such sale and leaseback transaction.Section 5.03. Limitation on Sale and Leaseback Transactions.Full wording and supporting evidence
Source evidence: The Company will not, and will not permit any of its Restricted Subsidiaries to, enter into any sale and leaseback transaction; provided that the Company or any Guarantor may enter into a sale and leaseback transaction if (i) the Company or such Guarantor, as applicable, could have incurred a Lien to secure such Indebtedness in an amount equal to the Attributable Indebtedness relating to such sale and leaseback transaction pursuant to the provisions of Section 5.02 hereof and (ii) the gross cash proceeds of such sale and leaseback transaction are at least equal to the fair market value (as determined in good faith by the Board of Directors of the Company and set forth in an Officers' Certificate delivered to the Trustee) of the property that is the subject of such sale and leaseback transaction.
Target identity evidence: THIS TWENTY-SECOND SUPPLEMENTAL INDENTURE (this "Supplemental Indenture"), by and among Cencora, Inc., a Delaware corporation (hereinafter called the "Company"), and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), a national banking association organized and existing under the laws of the United States of America, as trustee (hereinafter called the "Trustee"), is made and entered into as of this 13^th^ day of February, 2026.
Target identity evidence: The Company has heretofore executed and delivered to the Trustee an indenture, dated as of November 19, 2009 (as such indenture has been amended, supplemented or otherwise modified prior to the date hereof, the "Base Indenture"), providing for the issuance of the Company's unsecured debentures, notes, bonds, and other evidences of indebtedness, to be issued in one or more fully registered series (the "Securities").
Target identity evidence: Pursuant to Section 3.01 of the Base Indenture, the Company desires to provide for the establishment of a new series of Securities under the Base Indenture to be known as its "5.650% Senior Notes due 2056" (the "2056 Notes"), the form and substance and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and this Supplemental Indenture.
Target scope evidence: In addition to the covenants set forth in Article 10 of the Base Indenture, the following additional covenants shall apply with respect to the 2056 Notes.
The Company has heretofore executed and delivered to the Trustee an indenture (the “**Base Indenture**”), dated as of November 19, 2009, between the Company and the Trustee, as such indenture has been amended, supplemented or otherwise modified prior to February 13, 2026 and, as amended and supplemented by a Twenty-Second supplemental indenture thereto (the “**Twenty-Second Supplemental Indenture**” and, together with the Base Indenture, the “**Indenture**”), dated as of February 13, 2026, among the Company and the Trustee, providing for the original issuance of an aggregate principal amount of $500 million ($500,000,000) of the Company’s 5.650% Senior Notes due 2056 (the “**2056 Notes**”).
Issuer evidence: This JOINDER TO TWENTY-SECOND SUPPLEMENTAL INDENTURE (this “**Joinder**”), dated as of \_\_\_\_\_\_\_\_\_\_\_\_\_, 20\_\_, among \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ (the “**Guarantor[s]**”), [each] a subsidiary of Cencora, Inc. (or [its/their] permitted successor[s]), a Delaware corporation (the “**Company**”), the Company and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee under the Twenty-Second Supplemental Indenture referred to below (the “**Trustee**”).
Supporting evidence: The Company has heretofore executed and delivered to the Trustee an indenture (the “**Base Indenture**”), dated as of November 19, 2009, between the Company and the Trustee, as such indenture has been amended, supplemented or otherwise modified prior to February 13, 2026 and, as amended and supplemented by a Twenty-Second supplemental indenture thereto (the “**Twenty-Second Supplemental Indenture**” and, together with the Base Indenture, the “**Indenture**”), dated as of February 13, 2026, among the Company and the Trustee, providing for the original issuance of an aggregate principal amount of $500 million ($500,000,000) of the Company’s 5.650% Senior Notes due 2056 (the “**2056 Notes**”).
Supporting evidence: The Company has heretofore executed and delivered to the Trustee an indenture (the “**Base Indenture**”), dated as of November 19, 2009, between the Company and the Trustee, as such indenture has been amended, supplemented or otherwise modified prior to February 13, 2026 and, as amended and supplemented by a Twenty-Second supplemental indenture thereto (the “**Twenty-Second Supplemental Indenture**” and, together with the Base Indenture, the “**Indenture**”), dated as of February 13, 2026, among the Company and the Trustee, providing for the original issuance of an aggregate principal amount of $500 million ($500,000,000) of the Company’s 5.650% Senior Notes due 2056 (the “**2056 Notes**”).
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
0.22×
Medical Distribution median 0.86×
EV/EBIT
23.96×
P/E (TTM)
24.89×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
Component
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
US Healthcare Solutions
$290,982,023,000
$265,339,427,000
$234,759,218,000
$212,100,202,000
$202,461,545,000
—
—
—
International Healthcare Solutions
$30,366,323,000
$28,627,542,000
$27,418,679,000
$26,491,673,000
$11,529,629,000
$3,508,106,000
—
—
Global Commercialization Services
—
—
—
—
—
$3,308,640,000
—
$2,542,971,000
MWI Animal Health
—
—
—
—
—
$4,216,462,000
—
$3,789,759,000
Pharmaceutical Distribution
—
—
—
—
—
$182,467,189,000
$172,813,537,000
$161,699,343,000
All Other Segments
—
—
—
—
—
$7,525,102,000
$6,868,341,000
$6,332,730,000
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
